Integrative Analysis with Monte Carlo Cross-Validation Reveals miRNAs Regulating Pathways Cross-Talk in Aggressive Breast Cancer
暂无分享,去创建一个
[1] L. Varani,et al. Interleukin-1 beta induces the expression and production of stem cell factor by epithelial cells: crucial involvement of the PI-3K/mTOR pathway and HIF-1 transcription complex , 2014, Cellular and Molecular Immunology.
[2] F. Feng,et al. Development and Validation of a Novel Platform-Independent Metastasis Signature in Human Breast Cancer , 2015, PloS one.
[3] Carlos Caldas,et al. BRCA1‐like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential , 2015, Molecular oncology.
[4] Sha Cao,et al. Cancer may be a pathway to cell survival under persistent hypoxia and elevated ROS: A model for solid‐cancer initiation and early development , 2015, International journal of cancer.
[5] Shuiping Gao,et al. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling , 2015, Oncotarget.
[6] Guangyu Liu,et al. Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer , 2015, Oncotarget.
[7] R. Roberts,et al. Heightened potency of human pluripotent stem cell lines created by transient BMP4 exposure , 2015, Proceedings of the National Academy of Sciences.
[8] Fengfeng Wang,et al. Gene Network Exploration of Crosstalk between Apoptosis and Autophagy in Chronic Myelogenous Leukemia , 2015, BioMed research international.
[9] H. Wildiers,et al. Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management , 2015, Breast Cancer Research.
[10] L. Du,et al. Serum microRNA expression signatures identified from genome‐wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer , 2015, International journal of cancer.
[11] P. Tan,et al. Cancer stem cell and epithelial–mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast , 2015, Breast Cancer Research and Treatment.
[12] Lihua Wang,et al. Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis , 2015, BioMed research international.
[13] M. Polenaković,et al. Proteomics analysis of urine reveals acute phase response proteins as candidate diagnostic biomarkers for prostate cancer , 2015, Proteome Science.
[14] Lu‐Hai Wang,et al. Regulation of cancer metastasis by microRNAs , 2015, Journal of Biomedical Science.
[15] Myles Brown,et al. Loss of estrogen-regulated microRNA expression increases HER2 signaling and is prognostic of poor outcome in luminal breast cancer. , 2015, Cancer research.
[16] S. Xie,et al. Reduced expression levels of let-7c in human breast cancer patients , 2015, Oncology letters.
[17] Hyunju Lee,et al. A Computational Approach to Identifying Gene-microRNA Modules in Cancer , 2015, PLoS Comput. Biol..
[18] R. Eils,et al. BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence , 2014, Nature Genetics.
[19] S. Thibodeau,et al. Prostate cancer risk locus at 8q24 as a regulatory hub by physical interactions with multiple genomic loci across the genome. , 2015, Human molecular genetics.
[20] P. Tassone,et al. A p53‐Dependent Tumor Suppressor Network Is Induced by Selective miR‐125a‐5p Inhibition in Multiple Myeloma Cells , 2014, Journal of cellular physiology.
[21] Y. Xiong,et al. NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells. , 2014, The Journal of clinical investigation.
[22] T. McKay,et al. Cell signalling pathways underlying induced pluripotent stem cell reprogramming. , 2014, World journal of stem cells.
[23] T. Koru-Sengul,et al. A Novel MAPK–microRNA Signature Is Predictive of Hormone-Therapy Resistance and Poor Outcome in ER-Positive Breast Cancer , 2014, Clinical Cancer Research.
[24] C. Lange,et al. Abstract 2107: Aurora A kinase and progesterone receptor cross talk in breast cancer , 2014 .
[25] Jian-jun Zhao,et al. Crosstalk between microRNA30a/b/c/d/e-5p and the canonical Wnt pathway: implications for multiple myeloma therapy. , 2014, Cancer research.
[26] Crispin J. Miller,et al. Epithelial and Stromal MicroRNA Signatures of Columnar Cell Hyperplasia Linking Let-7c to Precancerous and Cancerous Breast Cancer Cell Proliferation , 2014, PloS one.
[27] U. Lehmann,et al. DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma. , 2014, World journal of gastroenterology.
[28] Giancarlo Mauri,et al. Integration of mRNA Expression Profile, Copy Number Alterations, and microRNA Expression Levels in Breast Cancer to Improve Grade Definition , 2014, PloS one.
[29] S. Ambs,et al. Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression , 2014, Proceedings of the National Academy of Sciences.
[30] Xaralabos Varelas,et al. The Transcriptional Regulators TAZ and YAP Direct Transforming Growth Factor β-induced Tumorigenic Phenotypes in Breast Cancer Cells*♦ , 2014, The Journal of Biological Chemistry.
[31] B. LaFleur,et al. Polyamines are oncometabolites that regulate the LIN28/let‐7 pathway in colorectal cancer cells , 2014, Molecular carcinogenesis.
[32] Adam G. Diehl,et al. Molecular and Cellular Pathobiology The Notch Pathway Inhibits TGF b Signaling in Breast Cancer through HEYL-Mediated Crosstalk , 2014 .
[33] M. Knowles,et al. Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity , 2014, Nature Reviews Cancer.
[34] Isabella Castiglioni,et al. Pathway-based expression profile for breast cancer diagnoses , 2014, 2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[35] Giancarlo Mauri,et al. Combined analysis of chromosomal instabilities and gene expression for colon cancer progression inference , 2014, Journal of Clinical Bioinformatics.
[36] Antonio Colaprico,et al. An Approach to Identify miRNA Associated with Cancer Altered Pathways , 2013, ICIAP Workshops.
[37] S. Pastoreková,et al. Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses , 2013, Molecular Cancer.
[38] S. Drăghici,et al. Analysis and correction of crosstalk effects in pathway analysis , 2013, Genome research.
[39] G. Wang,et al. Mediator MED15 modulates transforming growth factor beta (TGFβ)/Smad signaling and breast cancer cell metastasis. , 2013, Journal of molecular cell biology.
[40] E. Sonnhammer,et al. Statistical Assessment of Crosstalk Enrichment between Gene Groups in Biological Networks , 2013, PloS one.
[41] W. Xie,et al. miR-181a and inflammation: miRNA homeostasis response to inflammatory stimuli in vivo. , 2013, Biochemical and biophysical research communications.
[42] René Bernards,et al. A Missing Link in Genotype-Directed Cancer Therapy , 2012, Cell.
[43] Zuhong Lu,et al. Analysis of serum genome-wide microRNAs for breast cancer detection. , 2012, Clinica chimica acta; international journal of clinical chemistry.
[44] L. Hunyady,et al. Crosstalk between TGF-β signaling and the microRNA machinery. , 2012, Trends in pharmacological sciences.
[45] Diogo M. Camacho,et al. Wisdom of crowds for robust gene network inference , 2012, Nature Methods.
[46] M. Hashemi,et al. Genetic pathways linking hemostasis and cancer. , 2012, Thrombosis research.
[47] W. Ruf,et al. Tissue factor proangiogenic signaling in cancer progression. , 2012, Thrombosis research.
[48] B. Mehrara,et al. HIF‐1α: coordinates lymphangiogenesis during wound healing and in response to inflammation , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[49] P. Reitsma,et al. The relationship between tissue factor and cancer progression: insights from bench and bedside. , 2012, Blood.
[50] M. Neubauer,et al. Thrombotic microangiopathy and disseminated intravascular coagulation associated with carcinocythemia in a patient with breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[51] Chao Cheng,et al. Average Rank-Based Score to Measure Deregulation of Molecular Pathway Gene Sets , 2011, PloS one.
[52] Stefano Volinia,et al. miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia. , 2011, Blood.
[53] Qi Zhou,et al. Prognostic Significance of miR-181b and miR-21 in Gastric Cancer Patients Treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin , 2011, PloS one.
[54] W. Ruf,et al. Tissue factor and cell signalling in cancer progression and thrombosis , 2011, Journal of thrombosis and haemostasis : JTH.
[55] Gabriele Sales,et al. parmigene - a parallel R package for mutual information estimation and gene network reconstruction , 2011, Bioinform..
[56] C. Sotiriou,et al. Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer , 2011, PloS one.
[57] P. Marcato,et al. Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform , 2011, Cell cycle.
[58] Anthony Fyles,et al. MicroRNA-301 mediates proliferation and invasion in human breast cancer. , 2011, Cancer research.
[59] Peter Carmeliet,et al. Hypoxia and inflammation. , 2011, The New England journal of medicine.
[60] D. Yee,et al. MicroRNAs Link Estrogen Receptor Alpha Status and Dicer Levels in Breast Cancer , 2010, Hormones & cancer.
[61] Riet De Smet,et al. Advantages and limitations of current network inference methods , 2010, Nature Reviews Microbiology.
[62] Zhiwei Wang,et al. Cross-talk between miRNA and Notch signaling pathways in tumor development and progression. , 2010, Cancer Letters.
[63] F. Ferrari,et al. A MicroRNA Targeting Dicer for Metastasis Control , 2010, Cell.
[64] Mariano J. Alvarez,et al. A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers , 2010, Molecular systems biology.
[65] Xi Chen,et al. The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma. , 2010, European journal of cancer.
[66] Hua Su,et al. MicroRNA-9 coordinates proliferation and migration of human embryonic stem cell-derived neural progenitors. , 2010, Cell stem cell.
[67] S. Johnston,et al. New Strategies in Estrogen Receptor–Positive Breast Cancer , 2010, Clinical Cancer Research.
[68] Mark D. Robinson,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[69] K. Kashiwagi,et al. Modulation of cellular function by polyamines. , 2010, The international journal of biochemistry & cell biology.
[70] E. Dougherty,et al. Accurate and Reliable Cancer Classification Based on Probabilistic Inference of Pathway Activity , 2009, PloS one.
[71] A. Falanga,et al. Venous thromboembolism in the hematologic malignancies. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[72] Doheon Lee,et al. Inferring Pathway Activity toward Precise Disease Classification , 2008, PLoS Comput. Biol..
[73] R. Johnson,et al. Hypoxia: A key regulator of angiogenesis in cancer , 2007, Cancer and Metastasis Reviews.
[74] J. Rak,et al. The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression. , 2007, Thrombosis research.
[75] Andy Liaw,et al. Classification and Regression by randomForest , 2007 .
[76] Emmanuel Barillot,et al. Classification of microarray data using gene networks , 2007, BMC Bioinformatics.
[77] Joshy George,et al. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. , 2006, Cancer research.
[78] C. Nguyen,et al. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q , 2006, British Journal of Cancer.
[79] M. J. van de Vijver,et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. , 2006, Journal of the National Cancer Institute.
[80] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[81] Jun Lu,et al. Pathway level analysis of gene expression using singular value decomposition , 2005, BMC Bioinformatics.
[82] S. Shirasawa,et al. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. , 2005, Blood.
[83] Qing Wang,et al. Towards precise classification of cancers based on robust gene functional expression profiles , 2005, BMC Bioinformatics.
[84] A. Kraskov,et al. Estimating mutual information. , 2003, Physical review. E, Statistical, nonlinear, and soft matter physics.
[85] R. Jaenisch,et al. HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation , 2003, Cell.
[86] A. Ohta,et al. Differential Regulation of Two Alternatively Spliced Isoforms of Hypoxia-inducible Factor-1α in Activated T Lymphocytes* , 2001, The Journal of Biological Chemistry.
[87] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[88] T. Barbui,et al. The Effect of Very-low-dose Warfarin on Markers of Hypercoagulation in Metastatic Breast Cancer: Results from a Randomized Trial , 1998, Thrombosis and Haemostasis.
[89] Holger Karas,et al. TRANSFAC: a database on transcription factors and their DNA binding sites , 1996, Nucleic Acids Res..
[90] Chenqi Zhao,et al. Hormonal and Feedback Regulation of Putrescine and Spermidine Transport in Human Breast Cancer Cells (*) , 1995, The Journal of Biological Chemistry.
[91] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[92] T S Edgington,et al. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.